Association of Fatal and Nonfatal Cardiovascular Outcomes With 24-Hour Mean Arterial Pressure

Supplemental Digital Content is available in the text. Major adverse cardiovascular events are closely associated with 24-hour blood pressure (BP). We determined outcome-driven thresholds for 24-hour mean arterial pressure (MAP), a BP index estimated by oscillometric devices. We assessed the association of major adverse cardiovascular events with 24-hour MAP, systolic BP (SBP), and diastolic BP (DBP) in a population-based cohort (n=11 596). Statistics included multivariable Cox regression and the generalized R2 statistic to test model fit. Baseline office and 24-hour MAP averaged 97.4 and 90.4 mm Hg. Over 13.6 years (median), 2034 major adverse cardiovascular events occurred. Twenty-four-hour MAP levels of <90 (normotension, n=6183), 90 to <92 (elevated MAP, n=909), 92 to <96 (stage-1 hypertension, n=1544), and ≥96 (stage-2 hypertension, n=2960) mm Hg yielded equivalent 10-year major adverse cardiovascular events risks as office MAP categorized using 2017 American thresholds for office SBP and DBP. Compared with 24-hour MAP normotension, hazard ratios were 0.96 (95% CI, 0.80–1.16), 1.32 (1.15–1.51), and 1.77 (1.59–1.97), for elevated and stage-1 and stage-2 hypertensive MAP. On top of 24-hour MAP, higher 24-hour SBP increased, whereas higher 24-hour DBP attenuated risk (P<0.001). Considering the 24-hour measurements, R2 statistics were similar for SBP (1.34) and MAP (1.28), lower for DBP than for MAP (0.47), and reduced to null, if the base model included SBP and DBP; if the ambulatory BP indexes were dichotomized according to the 2017 American guideline and the proposed 92 mm Hg for MAP, the R2 values were 0.71, 0.89, 0.32, and 0.10, respectively. In conclusion, the clinical application of 24-hour MAP thresholds in conjunction with SBP and DBP refines risk estimates.

[1]  E. O’Brien,et al.  Opposing Age-Related Trends in Absolute and Relative Risk of Adverse Health Outcomes Associated With Out-of-Office Blood Pressure. , 2019, Hypertension.

[2]  E. O’Brien,et al.  Association of Office and Ambulatory Blood Pressure With Mortality and Cardiovascular Outcomes. , 2019, JAMA.

[3]  Deepak L. Bhatt,et al.  Effect of Systolic and Diastolic Blood Pressure on Cardiovascular Outcomes. , 2019, The New England journal of medicine.

[4]  Thomas Kahan,et al.  [2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)]. , 2018, Giornale italiano di cardiologia.

[5]  E. O’Brien,et al.  Evidence-based proposal for the number of ambulatory readings required for assessing blood pressure level in research settings: an analysis of the IDACO database , 2018, Blood pressure.

[6]  L. Mena,et al.  Glaucomatous Optic Neuropathy Associated with Nocturnal Dip in Blood Pressure: Findings from the Maracaibo Aging Study. , 2018, Ophthalmology.

[7]  Jackson T. Wright,et al.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Journal of the American College of Cardiology.

[8]  José R. Banegas,et al.  Relationship between Clinic and Ambulatory Blood‐Pressure Measurements and Mortality , 2018, The New England journal of medicine.

[9]  G. Lip,et al.  Ambulatory blood pressure and long-term risk for atrial fibrillation , 2018, Heart.

[10]  J. Spence Systolic blood pressure targets, diastolic J curve and cuff artefact in blood pressure measurement: a note of caution , 2017, European journal of neurology.

[11]  J. Staessen,et al.  Office and Home Blood Pressures as Determinants of Electrocardiographic Left Ventricular Hypertrophy Among Black Nigerians Compared With White Flemish , 2017, American journal of hypertension.

[12]  P. López-Jaramillo,et al.  A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension , 2016, The Lancet.

[13]  J. Coresh,et al.  60 A comparison of HFrEF vs HFpEF’s clinical workload and cost in the first year following hospitalisation and enrollment in a disease management program , 2016, Journal of the American College of Cardiology.

[14]  Jackson T. Wright,et al.  A Randomized Trial of Intensive versus Standard Blood-Pressure Control. , 2016, The New England journal of medicine.

[15]  J. Staessen,et al.  The Diurnal Profile of Central Hemodynamics in a General Uruguayan Population. , 2016, American journal of hypertension.

[16]  K. Asayama,et al.  Long-Term Stroke Risk Due to Partial White-Coat or Masked Hypertension Based on Home and Ambulatory Blood Pressure Measurements: The Ohasama Study , 2016, Hypertension.

[17]  Hilmi R. Dajani,et al.  Oscillometric Blood Pressure Estimation: Past, Present, and Future , 2015, IEEE Reviews in Biomedical Engineering.

[18]  M. Pencina,et al.  How to interpret a small increase in AUC with an additional risk prediction marker: decision analysis comes through , 2014, Statistics in medicine.

[19]  J. Cockcroft,et al.  Central blood pressure: current evidence and clinical importance. , 2014, European heart journal.

[20]  Alan D. Lopez,et al.  A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[21]  Charles F Babbs,et al.  Oscillometric measurement of systolic and diastolic blood pressures validated in a physiologic mathematical model , 2012, Biomedical engineering online.

[22]  J. Staessen,et al.  Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. , 2011, JAMA.

[23]  Yutaka Imai,et al.  European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults , 2010, Blood pressure monitoring.

[24]  J. Staessen,et al.  Is "usual" blood pressure a proxy for 24-h ambulatory blood pressure in predicting cardiovascular outcomes? , 2008, American journal of hypertension.

[25]  J. Staessen,et al.  Independent prognostic value of the ambulatory arterial stiffness index and aortic pulse wave velocity in a general population , 2008, Journal of Human Hypertension.

[26]  J. Staessen,et al.  Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. , 2007, Blood pressure monitoring.

[27]  J. Staessen,et al.  Cardiovascular outcome in relation to progression to hypertension in the Copenhagen MONICA cohort. , 2007, American journal of hypertension.

[28]  J. Staessen,et al.  Diagnostic Thresholds for Ambulatory Blood Pressure Monitoring Based on 10-Year Cardiovascular Risk , 2007, Circulation.

[29]  E. Ingelsson,et al.  Diurnal blood pressure pattern and risk of congestive heart failure. , 2006, JAMA.

[30]  J. Staessen,et al.  Interaction between body mass index and alcohol intake in relation to blood pressure in HAN and SHE Chinese. , 2006, American journal of hypertension.

[31]  Michael F O'Rourke,et al.  Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. , 2005, Hypertension.

[32]  J. Staessen,et al.  Are published characteristics of the ambulatory blood pressure generalizable to rural Chinese? The JingNing population study , 2005, Blood pressure monitoring.

[33]  GuidoGrassi,et al.  Prognostic Value of Ambulatory and Home Blood Pressures Compared With Office Blood Pressure in the General Population , 2005 .

[34]  Yutaka Imai,et al.  Ambulatory Blood Pressure and 10-Year Risk of Cardiovascular and Noncardiovascular Mortality: The Ohasama Study , 2005, Hypertension.

[35]  S. Lewington Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies (vol 360, pg 1903, 2002) , 2003 .

[36]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[37]  M. Kikuya,et al.  Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study , 2002, Journal of hypertension.

[38]  E. O’Brien,et al.  Quality control of the blood pressure phenotype in the European Project on Genes in Hypertension , 2002, Blood pressure monitoring.

[39]  G. Maestre,et al.  The Maracaibo Aging Study: Population and Methodological Issues , 2002, Neuroepidemiology.

[40]  Jan A Staessen,et al.  Cardiovascular protection and blood pressure reduction: a meta-analysis , 2001, The Lancet.

[41]  J. Staessen,et al.  Ambulatory blood pressure of adults in Novosibirsk, Russia: interim report on a population study , 2000, Blood pressure monitoring.

[42]  E. O’Brien,et al.  Ambulatory blood pressure: normality and comparison with other measurements. , 1999, Hypertension.

[43]  C. Bulpitt,et al.  Reference values for ambulatory blood pressure: a population study. , 1991, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[44]  F. Mee,et al.  Twenty-four-hour ambulatory blood pressure in men and women aged 17 to 80 years: the Allied Irish Bank Study. , 1991, Journal of hypertension.

[45]  J. Staessen,et al.  Isolated systolic hypertension in the elderly. , 1990, Journal of hypertension.

[46]  M Laher,et al.  In search of Korotkoff. , 1982, British medical journal.

[47]  Thomas Kahan,et al.  [2018 ESC/ESH Guidelines for the management of arterial hypertension]. , 2019, Kardiologia polska.

[48]  C. Escobar Cervantes,et al.  [A randomized trial of intensive versus standard blood pressure control]. , 2016, Semergen.

[49]  J. Ärnlöv,et al.  Serum and dietary β-carotene and α-tocopherol and incidence of type 2 diabetes mellitus in a community-based study of Swedish men: report from the Uppsala Longitudinal Study of Adult Men (ULSAM) study , 2008, Diabetologia.

[50]  J. Staessen,et al.  An epidemiological approach to ambulatory blood pressure monitoring:the Belgian Population Study. , 1996, Blood pressure monitoring.